Advanced search
Publication Cover
Leukemia & Lymphoma Volume 61, 2020 - Issue 6
Submit an article Journal homepage
273
Views
2
CrossRef citations to date
0
Altmetric
Letters to the Editor

Grade 3A follicular lymphoma can be effectively controlled with very low-dose radiation therapy

Brandon S. ImberDepartment of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA; View further author information
,
Karen ChauDepartment of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA; View further author information
,
Eliana GoldbergDepartment of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA; View further author information
,
Erel JoffeLymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USAView further author information
&
Joachim YahalomDepartment of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Correspondence[email protected]
View further author information
Pages 1500-1503 | Received 30 Jun 2019, Accepted 08 Jan 2020, Published online: 09 Feb 2020

References

  • Yahalom J. Radiotherapy of follicular lymphoma: updated role and new rules. Curr Treat Options Oncol. 2014;15(2):262–268.
  • Vaidyanathan G, Czuczman MS. Follicular lymphoma grade 3: review and updates. Clin Lymphoma Myeloma Leuk. 2014;14(6):431–435.
  • Zelenetz AD. NCCN clinical practice guidelines in oncology: B-cell lymphomas. Version 2.2019. NCCN; 2019.
  • Brady JL, Binkley MS, Hajj C, et al. Definitive radiotherapy for localized follicular lymphoma staged by 18F-FDG PET-CT: a collaborative study by ILROG. Blood. 2019;133(3):237–245.
  • Shustik J, Quinn M, Connors JM, et al. Follicular non-Hodgkin lymphoma grades 3A and 3B have a similar outcome and appear incurable with anthracycline-based therapy. Ann Oncol. 2011;22(5):1164–1169.
  • Ali MM, Rouphail B, Dean RM, et al. Grade 3 follicular lymphoma: outcomes in the rituximab era. Blood. 2015;126:1520–1520.
  • Epperla N, Fenske TS, Olteanu H, et al. Outcomes of grade 3A follicular lymphoma: best treated as aggressive or indolent lymphoma? Blood. 2016;128(22):5328–5328.
  • Ayoub Z, Andraos T, Milgrom SA, et al. Limited stage grade 3 follicular lymphoma patients can experience favorable outcomes with combined modality therapy. Leuk Lymphoma. 2019;60(10):2432–2440.
  • Cheson BD, Fisher RI, Barrington SF, et al. Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification. JCO. 2014;32(27):3059–3068.
  • Hoskin PJ, Kirkwood AA, Popova B, et al. 4 Gy versus 24 Gy radiotherapy for patients with indolent lymphoma (FORT): a randomised phase 3 non-inferiority trial. Lancet Oncol. 2014;15(4):457–463.
  • Specht L. Radiotherapy for indolent lymphomas: how much is enough? Lancet Oncol. 2014;15(4):372–374.
  • Haas RLM, Poortmans P, de Jong D, et al. Effective palliation by low dose local radiotherapy for recurrent and/or chemotherapy refractory non-follicular lymphoma patients. Eur J Cancer. 2005;41(12):1724–1730.
  • Murthy V, Thomas K, Foo K, et al. Efficacy of palliative low-dose involved-field radiation therapy in advanced lymphoma: a phase II study. Clin Lymphoma Myeloma. 2008;8(4):241–245.
  • Brady JL, Attallah H, Mikhaeel NG. Outcome of low-dose palliative radiation therapy in relapsed or refractory high-grade non-Hodgkin lymphoma. Int J Radiat Oncol Biol Phys. 2016;96(2):E493.
  • Tanaka O, Oguchi M, Iida T, et al. Low dose palliative radiotherapy for refractory aggressive lymphoma. Rep Pract Oncol Radiother. 2016;21(6):495–499.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.